Published Oct 23, 2026
| Starting Price | Not publicly listed for core apps (enterprise quote) | Publishes list pricing for its Life Sciences Cloud | Not publicly listed (enterprise quote) |
| Best For | End-to-end life sciences suite with regulated workflows across R&D/Quality/Commercial | Commercial CRM and patient/provider engagement on the Salesforce platform; broad ecosystem | Organizations standardizing on a mature ECM for regulated document control (often legacy-heavy) |
| Key Strength | Domain-specific applications for regulated processes and a common platform across modules | Broad CRM ecosystem, configurability, published pricing | Mature content repository features and integrations in larger enterprises |
| Key Weakness | Reported issues include reporting limitations, workflow complexity, and cost; faces competition from Salesforce in commercial CRM | May require additional domain-specific tailoring for life sciences use cases | Can be complex to modernize and may lag modern SaaS UX in some areas |
Commercial CRM competition (Veeva vs Salesforce):
Quality and R&D differentiation:
Partner ecosystem as a delivery factor: